Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
asciminib (Scemblix) (1 trial)
irinotecan (Camptosar) (1 trial)
paclitaxel (taxol) (2 trials)
poziotinib (4 trials)
trastuzumab (herceptin) (1 trial)
yyb101 (2 trials)
jpi-547 (1 trial)
nov120401 (1 trial)
nov1501 (1 trial)
nov1601 (1 trial)
tew-7197 (1 trial)
venadaparib (1 trial)
Adenocarcinoma (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Breast Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Neoplasms (Phase 1)
Stomach Neoplasms (Phase 2)
Trials (13 total)
Trial APIs (12 total)